(Q45855259)

17 December 2017

title

Continuous infusion of factor IX concentrate to induce immune tolerance in two patients with haemophilia B. (English)

1 reference

17 December 2017

main subject

hemophilia

0 references

coagulation factor IX

0 references

hemophilia B

0 references

author name string

Tengborn L

series ordinal

1

1 reference

17 December 2017

Berntorp E

series ordinal

2

1 reference

17 December 2017

publication date

1 January 1998

1 reference

17 December 2017

published in

Haemophilia

1 reference

17 December 2017

volume

4

1 reference

17 December 2017

issue

1

1 reference

17 December 2017

page(s)

56-59

1 reference

17 December 2017

Results in three Australian haemophilia B patients with high-responding inhibitors treated with the Malmö model

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00142.X

Prevalence of factor IX inhibitors among patients with haemophilia B: results of a large-scale North American survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00142.X

Induction of split tolerance and clinical cure in high-responding hemophiliacs with factor IX antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00142.X

Adjusted dose continuous infusion of factor VIII in patients with haemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00142.X

Immune tolerance and the immune modulation protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00142.X

Factor IX inhibitors and anaphylaxis in haemophilia B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00142.X

10.1046/J.1365-2516.1998.00142.X

21 January 2018

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017